GC Biopharma Corp. (KRX:006280)

South Korea · Delayed Price · Currency is KRW

140,800

+700 (0.50%)

Apr 29, 2026, 9:10 AM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Manufacturing and Sales of Pharmaceuticals, Etc.	1.98T	1.58T	1.44T	1.48T	-
Manufacturing and Sales of Pharmaceuticals, Etc. Growth	25.40%	9.72%	-2.94%	-	-
Diagnosis and Analysis of Samples, Etc.	181.90B	200.12B	213.76B	262.18B	-
Diagnosis and Analysis of Samples, Etc. Growth	-9.10%	-6.38%	-18.47%	-	-
Consolidation Adjustment	-187.31B	-117.27B	-46.49B	-57.45B	-
Other	14.15B	16.06B	18.50B	22.10B	-
Other Growth	-11.92%	-13.17%	-16.29%	-	-
Energy Storage Device Manufacturing and Sales	-	-	-	-	1.54T
Total	1.99T	1.68T	1.63T	1.71T	1.54T
Total Growth	18.54%	3.27%	-4.95%	11.28%	2.24%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Consolidation	-187.31B	-117.27B	-46.49B	-57.45B	-
South Korea	1.55T	1.42T	1.40T	1.46T	9.50B
South Korea Growth	9.58%	1.16%	-4.23%	15297.99%	-99.26%
Overseas	626.44B	380.65B	272.87B	306.71B	39.46B
Overseas Growth	64.57%	39.50%	-11.03%	677.21%	-85.48%
Total	1.99T	1.68T	1.63T	1.71T	48.96B
Total Growth	18.54%	3.27%	-4.95%	3395.47%	-96.75%

Source: S&P Global Market Intelligence.